Related references
Note: Only part of the references are listed.Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection
O Preynat-Seauve et al.
JOURNAL OF IMMUNOLOGY (2006)
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor
AA Lugade et al.
JOURNAL OF IMMUNOLOGY (2005)
Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication
GJD van Mierlo et al.
JOURNAL OF IMMUNOLOGY (2004)
Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo
M Li et al.
JOURNAL OF IMMUNOLOGY (2001)
Tumor-specific CD4+ T cells have a major post-licensing role in CTL mediated anti-tumor immunity
AL Marzo et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
